ConductScience.org, home

Paper9743293

Induction of p53-dependent and p53-independent cellular responses by topoisomerase 1 inhibitors.

McDonald AC and 1 other. Br J Cancer, 1998. Cited by 61 papers, by iCite.

Cite this record

ConductScience Library. Induction of p53-dependent and p53-independent cellular responses by topoisomerase 1 inhibitors. Papers, record 9743293. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9743293

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Induction of p53-dependent and p53-independent cellular responses by topoisomerase 1 inhibitors.
PubMed
Journal
Br J Cancer
PubMed
Year
1998
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
61
iCite
Relative citation ratio, by iCite
1.37
iCite
Revised in PubMed
2019-05-15
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1McDonald ACA C
2Brown RR

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic Agents, PhytogenicMajor topic
CamptothecinMajor topic
Genes, p53Major topic
Ovarian NeoplasmsMajor topic
TopotecanMajor topic
Apoptosis
Cell Cycle
DNA Topoisomerases, Type I
Drug Resistance, Neoplasm
Female
Flow Cytometry
Humans
Irinotecan
Topoisomerase I Inhibitors
Tumor Cells, Cultured
Tumor Stem Cell Assay
Tumor Suppressor Protein p53

Source PubMed

Download CSV of topics

References37

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
18426740Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents.Oncogene1993https://conductscience.org/library/papers/8426740PubMed
29288734Cell-cycle arrest versus cell death in cancer therapy.Nat Med1997https://conductscience.org/library/papers/9288734PubMed
38319228The cell cycle related differences in susceptibility of HL-60 cells to apoptosis induced by various antitumor agents.Cancer Res1993https://conductscience.org/library/papers/8319228PubMed
48364909Loss of a p53-associated G1 checkpoint does not decrease cell survival following DNA damage.Cancer Res1993https://conductscience.org/library/papers/8364909PubMed
58402660Role of the p53 tumor suppressor gene in cell cycle arrest and radiosensitivity of Burkitt's lymphoma cell lines.Cancer Res1993https://conductscience.org/library/papers/8402660PubMed
68406999Increased accumulation of p53 protein in cisplatin-resistant ovarian cell lines.Int J Cancer1993https://conductscience.org/library/papers/8406999PubMed
78106143Cross-resistance to diverse drugs is associated with primary cisplatin resistance in ovarian cancer cell lines.Cancer Res1993https://conductscience.org/library/papers/8106143PubMed
87505830Dose-intense taxol: high response rate in patients with platinum-resistant recurrent ovarian cancer.J Natl Cancer Inst1994https://conductscience.org/library/papers/7505830PubMed
98114714DNA strand breaks: the DNA template alterations that trigger p53-dependent DNA damage response pathways.Mol Cell Biol1994https://conductscience.org/library/papers/8114714PubMed
108137244Camptothecins: from bench research to hospital wards.Cancer Res1994https://conductscience.org/library/papers/8137244PubMed
118033090Cell cycle arrests and radiosensitivity of human tumor cell lines: dependence on wild-type p53 for radiosensitivity.Cancer Res1994https://conductscience.org/library/papers/8033090PubMed
127954409p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents.Cancer Res1994https://conductscience.org/library/papers/7954409PubMed
137529916Evidence for a second cell cycle block at G2/M by p53.Oncogene1995https://conductscience.org/library/papers/7529916PubMed
147667317p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts.Proc Natl Acad Sci U S A1995https://conductscience.org/library/papers/7667317PubMed
157669555The genetic analysis of ovarian cancer.Br J Cancer1995https://conductscience.org/library/papers/7669555PubMed
167577037CPT-11 (irinotecan) in the treatment of colorectal cancer.Eur J Cancer1995https://conductscience.org/library/papers/7577037PubMed
178564846Loss of normal p53 function confers sensitization to Taxol by increasing G2/M arrest and apoptosis.Nat Med1996https://conductscience.org/library/papers/8564846PubMed
188564971Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems.Cancer Res1996https://conductscience.org/library/papers/8564971PubMed
198640828Microsatellite instability, apoptosis, and loss of p53 function in drug-resistant tumor cells.Cancer Res1996https://conductscience.org/library/papers/8640828PubMed
208654922p53: puzzle and paradigm.Genes Dev1996https://conductscience.org/library/papers/8654922PubMed

See all 37 referencesDownload CSV of references

Cited by22

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 61 citations.

PMIDTitleJournalYearIn PapersSource
35008354Targeted Disruption of E6/p53 Binding Exerts Broad Activity and Synergism with Paclitaxel and Topotecan against HPV-Transformed Cancer Cells.Cancers (Basel)2021https://conductscience.org/library/papers/35008354PubMed
28453558Tumor-targeted SN38 inhibits growth of early stage non-small cell lung cancer (NSCLC) in a KRas/p53 transgenic mouse model.PLoS One2017https://conductscience.org/library/papers/28453558PubMed
27267850A Novel HSP90 Inhibitor-Drug Conjugate to SN38 Is Highly Effective in Small Cell Lung Cancer.Clin Cancer Res2016https://conductscience.org/library/papers/27267850PubMed
26657503Inhibition of hypoxia inducible factor 1 and topoisomerase with acriflavine sensitizes perihilar cholangiocarcinomas to photodynamic therapy.Oncotarget2016https://conductscience.org/library/papers/26657503PubMed
24829906The molecular mechanisms of Tanshinone IIA on the apoptosis and arrest of human esophageal carcinoma cells.Biomed Res Int2014https://conductscience.org/library/papers/24829906PubMed
23537372UCN-01 induces S and G2/M cell cycle arrest through the p53/p21(waf1) or CHK2/CDC25C pathways and can suppress invasion in human hepatoma cell lines.BMC Cancer2013https://conductscience.org/library/papers/23537372PubMed
23469123Altered processing of amyloid precursor protein in cells undergoing apoptosis.PLoS One2013https://conductscience.org/library/papers/23469123PubMed
23180349Lack of Bax expression is associated with irinotecan-based treatment activity in advanced colorectal cancer patients.Clin Transl Oncol2013https://conductscience.org/library/papers/23180349PubMed
21372224Humanized anti-Trop-2 IgG-SN-38 conjugate for effective treatment of diverse epithelial cancers: preclinical studies in human cancer xenograft models and monkeys.Clin Cancer Res2011https://conductscience.org/library/papers/21372224PubMed
20504876Defective p53 antiangiogenic signaling in glioblastoma.Neuro Oncol2010https://conductscience.org/library/papers/20504876PubMed
20196838Pregnane X Receptor (PXR) expression in colorectal cancer cells restricts irinotecan chemosensitivity through enhanced SN-38 glucuronidation.Mol Cancer2010https://conductscience.org/library/papers/20196838PubMed
19727814P53 and p38 MAPK pathways are involved in MONCPT-induced cell cycle G2/M arrest in human non-small cell lung cancer A549.J Cancer Res Clin Oncol2010https://conductscience.org/library/papers/19727814PubMed
19445707Increased susceptibility of spinal muscular atrophy fibroblasts to camptothecin is p53-independent.BMC Cell Biol2009https://conductscience.org/library/papers/19445707PubMed
17164761Schedule-dependent activity of 5-fluorouracil and irinotecan combination in the treatment of human colorectal cancer: in vitro evidence and a phase I dose-escalating clinical trial.Br J Cancer2007https://conductscience.org/library/papers/17164761PubMed
16280599High salt culture conditions suppress proliferation of rat C6 glioma cell by arresting cell-cycle progression at S-phase.J Mol Neurosci2005https://conductscience.org/library/papers/16280599PubMed
12032863Enhanced tumor killing by Apo2L/TRAIL and CPT-11 co-treatment is associated with p21 cleavage and differential regulation of Apo2L/TRAIL ligand and its receptors.Oncogene2002https://conductscience.org/library/papers/12032863PubMed
11986787Effect of non-steroidal anti-inflammatory drugs on colon carcinoma Caco-2 cell responsiveness to topoisomerase inhibitor drugs.Br J Cancer2002https://conductscience.org/library/papers/11986787PubMed
11961671Intraperitoneal adenovirus-mediated suicide gene therapy in combination with either topotecan or paclitaxel in nude mice with human ovarian cancer.Cancer Gene Ther2002https://conductscience.org/library/papers/11961671PubMed
11313813Replication and cytolysis of an E1B-attenuated adenovirus in drug-resistant ovarian tumour cells is associated with reduced apoptosis.Gene Ther2001https://conductscience.org/library/papers/11313813PubMed
10980131Expression of p57(KIP2) potently blocks the growth of human astrocytomas and induces cell senescence.Am J Pathol2000https://conductscience.org/library/papers/10980131PubMed

See all 22 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
TP537157PubTator's text mininghttps://conductscience.org/library/genes/7157

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/9743293

GET https://conductscience.org/api/papers/v1/9743293/references?page=2